Samsara BioCapital, L.P. 13D/13G Filings for Lyra Therapeutics, Inc. (LYRA)

Samsara BioCapital, L.P. 13D and 13G filings for Lyra Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
5:48 pm
Purchase		 2024-09-30 13G Lyra Therapeutics, Inc.
LYRA		 Samsara BioCapital, L.P. 3,281,766
4.980%		 501,505increase
(+18.04%)		 Filing
2023-08-25
4:15 pm
Purchase		 2022-04-12 13G Lyra Therapeutics, Inc.
LYRA		 Samsara BioCapital, L.P. 2,780,261
5.600%		 2,780,261increase
(New Position)		 Filing